The advantage of choosing OmniAb for discovery
OmniAb partners enjoy access to the most comprehensive and cutting-edge suite of clinically proven antibody discovery technologies available. We offer validated and proprietary transgenic animals capable of generating high-quality, fully human antibodies to help identify the ideal therapeutic.
Naturally Optimized In Vivo Peptide Discovery
OmniTides™ is a versatile in vivo peptide discovery platform, enabling discovery of tailored, naturally optimized peptides for multiple therapeutic applications. OmniTides delivers peptides pre-optimized for specificity, affinity, and structural stability, streamlining hit-to-lead identification.
What's New
at OmniAb
releases about OmniAb technology.
Explore Boldly. Screen Without Limits.
Discovery teams can now experience the advantages of xPloration’s fast processing speed, exceptional hit recovery, unparalleled ease-of-use and reliability in their own laboratories.
What's New at OmniAb
Read the latest news and press releases about OmniAb technology.
Publications & Presentations
Search and browse recent presentations and peer-reviewed publications about OmniAb technology
Become an OmniAb partner
See how over 100 biopharmaceutical companies and research institutions worldwide are using OmniAb technology and capabilities to advance clinical drug development. No other transgenic company serving the marketplace today offers the level of expertise and collaborative approach that we do. OmniAb provides the industry with several transgenic animal species. When you choose to work with us as your therapeutics company, we bring an exceptional amount of depth on our scientific team, meaning you can always expect the best from us.
Get in Touch
Learn about our antibody discovery services
and find out which could work best for you.